23 mai 2017 - Pembrolizumab Approved
Description:
FDA approved Pembrolizumab for specific tumors which have been identified to have a biomarker referred to as microsatellite instability-high. Meant for those who have undergone other treatments, and with no other alternatives.Ajouté au bande de temps:
Date:
23 mai 2017
Maintenaint
~ Il y a 8 ans et 4 mois